Cost Effectiveness Of Type 2 Diabetes Patients: A Research Framework

Keywords: Type 2 Diabetes; Cost Effectiveness; Management Accounting; 3Es; Value for Money


The growing of Metabolic Syndrome (MS) has contributed to higher risk and costs in managing Type 2 Diabetes patients. Diabetes patients are exposed to develop serious health complications. It can lead to related diseases affecting heart, eyes, kidneys, nerves and teeth. There is no proper framework on operation management and cost effectiveness in treating diabetes patients in Malaysia. Hence, it demanded on the elements and associated costs incurred by both healthcare provider and patients.

This paper adopted five stages in analyzing its relevant literatures. Cost effectiveness, healthcare provider, operation management and self-management were the literatures studied. It also highlighted on management accounting gained its relevancy and contribution towards health industry. As a result, a cost effectiveness of Type 2 Diabetes framework was developed. Cost effectiveness is a key component in determining value for money. This framework provides the value for money model for Type 2 Diabetes patients. The framework clearly provides the components of cost-effectiveness and 3Es: Economy, Efficiency; Effectiveness. Objectives, resources, input, processes, output, outcomes (intended or intended) and other influences are the components.

Author Biography


Accounting Lecturer

Department of Professional Accounting Studies, Faculty of Accountancy,

Universiti Teknologi MARA (UiTM), 40450 Shah Alam, Selangor, Malaysia


[1]. Margaret A. P., Joan, B., Marjorie, C., Paulina, D., Martha, M. F., Amy, H. F., Melinda, D. M., Linda, S., & Eva, V. (2015). Diabetes Self-management Education and Support in Type 2 Diabetes: A Joint Position Statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics. Diabetes Care 2015 Jul. 38(7): 1372-1382
[2]. Paige, C. F., Aviva, G. N., Michael, Q., Elbert, S. H., & Neda, L. (2017). Patients’ Future Expectations for Diabetes and Hypertension Treatments: Through the Diet… I Think This is Going to Go Away. Journal of General International Medicine, 32(1): 49–55

[3]. Sendi, P., Schellenberg, F., Ungsedhapand, C., Kaufman, G., Bucher, H., Weber, R., Battegay, M. and Swiss HIV Cohort Study (2004). Productivity Costs and Determinants of Productivity in HIV-Infected Patients. Clinical Therapeutics, Vol. 26, No. 5, p. 791 – 800
[4]. Vickerman, P., Kumaranayake, L., Balakireva, O., Guinness, G., Artyukh, O., Semikop, T., Yaremenko, O. & Watts, C. (2006). The Cost-Effectiveness of Expanding Ham Reduction Activities for Injecting Drug Users in Odessa, Ukraine. Sexually Trasmitted Diseases. Vol. 33, No. 10, p.S89-102
[5]. Weygandt, J., Kimmel, P. &Kieso, D. (2008). Managerial Accounting, John Wiley & Son
Yin, R. K. (1994). Case Study Research: Designs and Methods. Newberry Park, CA: Sage Publications.
How to Cite
SULAIMAN, S., & SAHOL, N. (2020). Cost Effectiveness Of Type 2 Diabetes Patients: A Research Framework. Archives of Business Research, 8(4), 116-131.